drugset / Trial / NCT03893487
Fimepinostat in Treating Brain Tumors in Children and Young Adults
Phase 0
Active not recruiting
30 enrolled
Sabine Mueller, MD, PhD
Cannonball Kids' Cancer Foundation · collabCuris, Inc. · collabPediatric Neuro-Oncology Consortium · collab
NaSingle-groupOpen-labelTreatment
Summary
This trial studies how well fimepinostat works in treating patients with newly diagnosed diffuse intrinsic pontine glioma, or medulloblastoma, or high-grade glioma that have come back. Fimepinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2019-08-07
- Primary completion
- 2022-10-31
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fimepinostat | Small molecule | — | Oral |